Possibilities and challenges for developing a successful vaccine for leishmaniasis - Wikidata - wikimedia - TriplyDB

Possibilities and challenges for developing a successful vaccine for leishmaniasis

Possibilities and challenges for developing a successful vaccine for leishmaniasis

http://www.wikidata.org/entity/Q26749758

about

Skin parasite landscape determines host infectiousness in visceral leishmaniasis.Diterpenes as lead molecules against neglected tropical diseases.The enemy within: Targeting host-parasite interaction for antileishmanial drug discovery Interplay of Regulatory T Cell and Th17 Cells during Infectious Diseases in Humans and Animals.Nerolidol, the main constituent of Piper aduncum essential oil, has anti-Leishmania braziliensis activity.Repurposing of Human Kinase Inhibitors in Neglected Protozoan Diseases.Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need.Nanostructured delivery systems with improved leishmanicidal activity: a critical review.Lipid-core nanocapsules increase the oral efficacy of quercetin in cutaneous leishmaniasis.Efficacy of intranasal LaAg vaccine against Leishmania amazonensis infection in partially resistant C57Bl/6 mice.Liposomal formulations in the pharmacological treatment of leishmaniasis: a review.Calcium Ionophore, Calcimycin, Kills Leishmania Promastigotes by Activating Parasite Nitric Oxide Synthase.Leishmaniasis in humans: drug or vaccine therapy?Leishmaniasis: current challenges and prospects for elimination with special focus on the South Asian region.Comparative study on the antileishmanial activities of chemically and biologically synthesized silver nanoparticles (AgNPs)Vaccination with whole-cell killed or recombinant leishmanial protein and toll-like receptor agonists against Leishmania tropica in BALB/c mice Growth arrested live-attenuated Leishmania infantum KHARON1 null mutants display cytokinesis defect and protective immunity in mice Macrophage Polarization in Leishmaniasis: Broadening Horizons

P2860

Q33875696-9073C40D-90E7-46B7-A25A-72F570031596 Q36206465-EEBF6292-1DDA-430A-87D9-72CD8DFD74A1 Q36395995-9617467F-902C-44B5-8932-03A03BDF1B2C Q37735221-177460BB-B646-4EEC-A42A-1254FA42F4C0 Q38797585-BDFA0168-2F24-46B3-8EA5-18F7B9A56437 Q38972808-7DB75013-BB46-40DA-983F-2E5EBE469797 Q39003990-9ED62413-0A9B-41C4-8585-C36D5066423A Q40099567-8CA4902D-6BDD-4891-8D05-13C027EC53DB Q40156682-68E8A2DB-E173-457D-84C7-CE71344D6229 Q40513787-71856115-CDB1-41C6-8632-9B42A20E92F4 Q43168913-2E62BF46-AE01-4E53-8317-9BAED0158CE0 Q46253085-024E5F07-0397-4A36-AD56-AA2ACAF26BD8 Q47556262-F0D5FEAF-4A8F-4FDF-A886-47652D3F85F2 Q52593359-6A4E35E4-75DE-43C6-9B85-7C9C1FAA90F0 Q57353298-51E29F66-FBDF-4EF1-AD4D-0B276F1BD5EB Q58701432-1DC4F6E7-D128-412D-B874-EC10A5CF68A2 Q58803575-7CE79056-67A8-4FEC-9424-EE399592A566 Q59138115-B42A098B-38A5-424E-981A-009FF0C3800E

P2860

Possibilities and challenges for developing a successful vaccine for leishmaniasis

http://www.wikidata.org/entity/Q26749758

description

2016 nî lūn-bûn

@nan

2016 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Possibilities and challenges for developing a successful vaccine for leishmaniasis

@ast

Possibilities and challenges for developing a successful vaccine for leishmaniasis

@en

Possibilities and challenges for developing a successful vaccine for leishmaniasis

@nl

type

label

Possibilities and challenges for developing a successful vaccine for leishmaniasis

@ast

Possibilities and challenges for developing a successful vaccine for leishmaniasis

@en

Possibilities and challenges for developing a successful vaccine for leishmaniasis

@nl

prefLabel

Possibilities and challenges for developing a successful vaccine for leishmaniasis

@ast

Possibilities and challenges for developing a successful vaccine for leishmaniasis

@en

Possibilities and challenges for developing a successful vaccine for leishmaniasis

@nl

P1433

Q26749758-50AEBAE8-5CEA-4DDC-94CD-74AB756BA442

P1476

Q26749758-056C3B59-512B-4B7C-9FA3-E46F242C4BB9

P2093

Q26749758-2A543DD5-662F-4947-A0BC-579F8D73FF05

Q26749758-54FA9E20-4032-4FE3-8B07-C7AD28D7D892

Q26749758-8D4BC65D-D896-479D-BEBF-7CD7323137D3

Q26749758-A593A2B6-3670-4108-BD60-A4035461655E

P275

Q26749758-71981DD3-8393-41FF-82B7-43F653C3CC34

P2860

Q26749758-0006BD5F-E8DE-44FD-ACA7-502E38D5630D

Q26749758-0D1EA351-8549-40A8-91E9-DFAF4CCA8D6D

Q26749758-1391A066-73E7-46E6-8FC2-B104E1EC34FC

Q26749758-175A46C3-402D-48E1-91B9-11ABCECD6FB7

Q26749758-192F9FD8-ADBA-40B1-ABB4-D994F8EB71BC

Q26749758-1B5622C4-F151-416C-8F72-EF7EFCC149B5

Q26749758-1BF8A969-20C1-413B-919E-8E3228AA5ABC

Q26749758-1D2B5E85-48A0-45ED-9D48-C69BCAFA16C7

Q26749758-21F1A826-03A0-46BA-8CA5-EB3E8F58FC77

Q26749758-23C882B8-D5F3-400C-A817-CD549C1A92C9

P2888

Q26749758-BCF6BDFF-2401-4D9B-8993-3E89798BB652

P304

Q26749758-6B038C8B-2443-4221-9AAA-8C85AF40DD4F

P31

Q26749758-21BB0777-D109-4362-B27B-38729E4247BB

Q26749758-BC6BE25A-1DAC-495D-A722-E513A77AF994

P3181

Q26749758-7ADC5C4B-11C6-4756-A2C8-BCB57B8397BC

P356

Q26749758-5A2272F5-61FA-425D-8EB4-CC3B53ABEC7D

P407

Q26749758-7B9B901C-5538-44BA-85E3-12CD6443DD57

P433

Q26749758-10EB95C3-D9D4-4950-A425-85775551A6AB

P478

Q26749758-52E68D14-D2DC-4469-98F9-E9FEC5A6F488

P5008

Q26749758-E6D9A7D9-86EA-45CC-B3FB-2FE084CBD5AF

P577

Q26749758-4EE0E6FB-E191-4B60-A355-E932A8FB7580

P6179

Q26749758-5D8226FE-7E21-4988-ACA2-64982CA1B81B

P698

Q26749758-47386EB2-5903-44A9-835E-AC993B6338E5

P921

Q26749758-758F5E99-8701-49A1-94DF-13E3E2FFA56A

Q26749758-7C10D9DF-C7A6-4E19-AAC5-40F45222100F

Q26749758-FB6B14BF-F222-46E9-8393-D539904BA425

P932

Q26749758-52DFA0C3-3950-451C-8E69-2D1AEF4C74BC

P3181

P356

S13071-016-1553-Y

P1433

Parasites & Vectors

P1476

Possibilities and challenges for developing a successful vaccine for leishmaniasis

@en

P2093

Jyotsna Mishra

http://www.w3.org/2001/XMLSchema#string

Prem Shankar

http://www.w3.org/2001/XMLSchema#string

Sarman Singh

http://www.w3.org/2001/XMLSchema#string

Saumya Srivastava

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Leishmaniasis worldwide and global estimates of its incidence

Toll-like receptor signalling

Function of Nod-like receptors in microbial recognition and host defense

IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani

Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis

IL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infection

IL-17 and Th17 Cells

Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-alpha: down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation

IL-22 increases the innate immunity of tissues

Adaptive immunity against Leishmania nucleoside hydrolase maps its c-terminal domain as the target of the CD4+ T cell-driven protective response

P2888

s13071-016-1553-y

P304

277

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1685085

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/S13071-016-1553-Y

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2016-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1041897263

http://www.w3.org/2001/XMLSchema#string

P698

27175732

http://www.w3.org/2001/XMLSchema#string

P921

Chin-hu̍t seng-bu̍t

vaccine development

P932

4866332

http://www.w3.org/2001/XMLSchema#string